Section Arrow
Quote
VRCA.NASDAQ
- Verrica Pharmaceuticals Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/08/19 17:05 EDT
After Hours
Last
 6.11
+0.06 (+0.99%)
Bid
6.11
Ask
6.29
High 6.29 
Low 6.05 
Volume 992 
Regular Hours
Last
 6.05
-0.105 (-1.71%)
Day High 
6.18 
Prev. Close
6.155 
1-M High
8.16 
Volume 
14.68K 
Bid
6.11
Ask
6.29
Day Low
5.985 
Open
6.04 
1-M Low
5.29 
Market Cap 
58.14M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 6.26 
20-SMA 6.31 
50-SMA 6.66 
52-W High 28.3 
52-W Low 3.816 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.74/-0.70
Enterprise Value
90.47M
Balance Sheet
Book Value Per Share
-1.85
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.57M
Operating Revenue Per Share
0.91
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
VKTXViking Therapeutics24.36-17.73-42.12%-- 
After Hours 24.8702 +0.5102 +2.09%
ADAPAdaptimmune Therapeutics plc0.062-0.008-11.43%-- 
After Hours 0.0625 +0.0005 +0.81%
IOVAIovance Biotherapeutics2.6+0.1+4.00%-- 
After Hours 2.59 -0.01 -0.38%
TNFATNF Pharmaceuticals Inc.0.0947-0.0071-6.97%-- 
After Hours 0.0935 -0.0012 -1.27%
RXRXRecursion Pharmaceuticals5.09-0.43-7.79%-- 
After Hours 5.0901 +0.0001 0.00%
Quotes are at least 15-min delayed：2025/08/19 17:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.